2017-2022 North America Injectable Anticoagulants Market Report

October 2017 | 115 pages | ID: 2710921A8D1EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In 2016, the North America Injectable Anticoagulants market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.

This report studies Injectable Anticoagulants in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering

• Sanofi
• Genentech (Roche)
• Boehringer Ingelheim
• Pfizer
• The Medicines Company
• Aspen
• Otsuka

Market Segment by Countries, this report splits North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 (forecast), like

• United States
• Canada
• Mexico

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into

• Low-molecular-weight Heparin (LMWH)
• Direct Thrombin Inhibitor (DTI)
• Other

Split by applications, this report focuses on sales, market share and growth rate of Injectable Anticoagulants in each application, can be divided into

• VTE
• ACS/MI
• AF
• Other

Contents

1 INJECTABLE ANTICOAGULANTS MARKET OVERVIEW

1.1 Product Overview and Scope of Injectable Anticoagulants
1.2 Injectable Anticoagulants Segment by Types
  1.2.1 North America Sales Market Share of Injectable Anticoagulants by Types in 2016
  1.2.2 Low-molecular-weight Heparin (LMWH)
    1.2.2.1 Major Players of Low-molecular-weight Heparin (LMWH)
  1.2.3 Direct Thrombin Inhibitor (DTI)
    1.2.3.1 Major Players of Direct Thrombin Inhibitor (DTI)
  1.2.4 Other
    1.2.4.1 Major Players of Other
1.3 Injectable Anticoagulants Segment by Applications
  1.3.1 Injectable Anticoagulants Sales Market Share by Applications in 2016
  1.3.2 VTE
  1.3.3 ACS/MI
  1.3.4 AF
  1.3.5 Other
1.4 Injectable Anticoagulants Market by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Canada Status and Prospect (2012-2022)
  1.4.3 Mexico Status and Prospect (2012-2022)
1.5 North America Injectable Anticoagulants Overview and Market Size (Value) (2012-2022)
  1.5.1 North America Market Injectable Anticoagulants Overview
  1.5.2 North America Market Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)

2 NORTH AMERICA INJECTABLE ANTICOAGULANTS SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 North America Injectable Anticoagulants Sales and Market Share in 2016 and 2017 by Players
2.2 North America Injectable Anticoagulants Revenue and Market Share by Players in 2016 and 2017
2.3 North America Injectable Anticoagulants Average Price by Players in 2016 and 2017
2.4 North America Injectable Anticoagulants Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Injectable Anticoagulants Market Competitive Situation and Trends
  2.5.1 Injectable Anticoagulants Market Concentration Rate
  2.5.2 Injectable Anticoagulants Market Share of Top 3 and Top 5 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 NORTH AMERICA INJECTABLE ANTICOAGULANTS SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)

3.1 North America Injectable Anticoagulants Sales, Revenue and Market Share by Countries (2012-2017)
  3.1.1 North America Injectable Anticoagulants Sales and Market Share by Countries (2012-2017)
  3.1.2 North America Injectable Anticoagulants Revenue and Market Share by Countries (2012-2017)
  3.1.3 North America Injectable Anticoagulants Price by Countries (2012-2017)
3.2 North America Injectable Anticoagulants Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.2.1 North America Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
  3.2.2 North America Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
  3.2.3 North America Injectable Anticoagulants Price by Type (2012-2017)
3.3 North America Injectable Anticoagulants Sales and Market Share by Application (2012-2017)
3.4 North America Market Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)

4 NORTH AMERICA INJECTABLE ANTICOAGULANTS PLAYERS PROFILES/ANALYSIS

4.1 Sanofi
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Injectable Anticoagulants Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Sanofi News
4.2 Genentech (Roche)
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Injectable Anticoagulants Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 Genentech (Roche) News
4.3 Boehringer Ingelheim
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Injectable Anticoagulants Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 Boehringer Ingelheim News
4.4 Pfizer
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Injectable Anticoagulants Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 Pfizer News
4.5 The Medicines Company
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Injectable Anticoagulants Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 The Medicines Company News
4.6 Aspen
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Injectable Anticoagulants Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Aspen News
4.7 Otsuka
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Injectable Anticoagulants Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
  4.7.5 Otsuka News

5 UNITED STATES INJECTABLE ANTICOAGULANTS SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

5.1 United States Injectable Anticoagulants Sales, Revenue and Growth Rate (2012-2017)
5.2 United States Injectable Anticoagulants Sales, Revenue and Market Share by Type (2012-2017)
  5.2.1 United States Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
  5.2.2 United States Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
  5.2.3 United States Injectable Anticoagulants Price by Type (2012-2017)
5.3 United States Injectable Anticoagulants Sales and Market Share by Application (2012-2017)

6 CANADA INJECTABLE ANTICOAGULANTS SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

6.1 Canada Injectable Anticoagulants Sales, Revenue and Growth Rate (2012-2017)
6.2 Canada Injectable Anticoagulants Sales, Revenue and Market Share by Type (2012-2017)
  6.2.1 Canada Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
  6.2.2 Canada Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
  6.2.3 Canada Injectable Anticoagulants Price by Type (2012-2017)
6.3 Canada Injectable Anticoagulants Sales and Market Share by Application (2012-2017)

7 MEXICO INJECTABLE ANTICOAGULANTS SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

7.1 Mexico Injectable Anticoagulants Sales, Revenue and Growth Rate (2012-2017)
7.2 Mexico Injectable Anticoagulants Sales, Revenue and Market Share by Type (2012-2017)
  7.2.1 Mexico Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
  7.2.2 Mexico Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
  7.2.3 Mexico Injectable Anticoagulants Price by Type (2012-2017)
7.3 Mexico Injectable Anticoagulants Sales and Market Share by Application (2012-2017)

8 NORTH AMERICA INJECTABLE ANTICOAGULANTS MARKET FORECAST (2017-2022)

8.1 North America Injectable Anticoagulants Sales, Revenue Forecast (2017-2022)
8.2 North America Injectable Anticoagulants Sales, Sales Forecast by Countries (2017-2022)
8.3 North America Injectable Anticoagulants Sales Forecast by Type (2017-2022)
8.4 North America Injectable Anticoagulants Sales Forecast by Application (2017-2022)
8.5 Injectable Anticoagulants Price Forecast (2017-2022)

9 INJECTABLE ANTICOAGULANTS MANUFACTURING COST ANALYSIS

9.1 Injectable Anticoagulants Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Injectable Anticoagulants

10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Injectable Anticoagulants Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Injectable Anticoagulants Major Players in 2016
10.4 Downstream Buyers

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Injectable Anticoagulants
Table Product Specifications of Injectable Anticoagulants
="Figure North America Sales Market Share of "&Sheet1!B1&" by Types in 2016
Table Types of Injectable Anticoagulants
Figure Product Picture of Low-molecular-weight Heparin (LMWH)
Table Major Players of Low-molecular-weight Heparin (LMWH)
Figure Product Picture of Direct Thrombin Inhibitor (DTI)
Table Major Players of Direct Thrombin Inhibitor (DTI)
Figure Product Picture of Other
Table Major Players of Other
Figure Injectable Anticoagulants Sales Market Share by Applications in 2016
="Table Applications of "&Sheet1!B1&"
Figure VTE Examples
Figure ACS/MI Examples
Figure AF Examples
Figure Other Examples
Figure United States Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure North America Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Table North America Injectable Anticoagulants Sales by Players in 2016 and 2017
Table North America Injectable Anticoagulants Sales Market Share (%) by Players in 2016 and 2017
Figure North America Injectable Anticoagulants Sales Market Share by Players in 2016
Figure North America Injectable Anticoagulants Sales Market Share by Players in 2017
Table North America Injectable Anticoagulants Revenue by Players in 2016 and 2017
Table North America Injectable Anticoagulants Revenue Market Share (%) by Players in 2016 and 2017
Figure North America Injectable Anticoagulants Revenue Market Share by Players in 2016
Figure North America Injectable Anticoagulants Revenue Market Share by Players in 2017
Table North America Injectable Anticoagulants Average Price by Players in 2016 and 2017
Figure North America Injectable Anticoagulants Average Price by Players in 2016
Table North America Injectable Anticoagulants Manufacturing Base Distribution and Sales Area by Players
Table Players Injectable Anticoagulants Product Types
Figure Injectable Anticoagulants Market Share of Top 3 Players
Figure Injectable Anticoagulants Market Share of Top 5 Players
Table North America Injectable Anticoagulants Sales by Countries (2012-2017)
Table North America Injectable Anticoagulants Sales Market Share by Countries (2012-2017)
Figure North America Injectable Anticoagulants Sales Market Share by Countries (2012)
Figure North America Injectable Anticoagulants Sales Market Share by Countries (2016)
Table North America Injectable Anticoagulants Revenue by Countries (2012-2017)
Table North America Injectable Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure 2012 North America Injectable Anticoagulants Revenue Market Share by Countries
Figure 2016 North America Injectable Anticoagulants Revenue Market Share by Countries
Table North America Injectable Anticoagulants Price by Countries (2012-2017)
Table North America Injectable Anticoagulants Sales by Type (2012-2017)
Table North America Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Figure 2012 North America Injectable Anticoagulants Sales Market Share by Type
Figure 2016 North America Injectable Anticoagulants Sales Market Share by Type
Table North America Injectable Anticoagulants Revenue by Type (2012-2017)
Table North America Injectable Anticoagulants Revenue Market Share by Type (2012-2017)
Figure 2012 North America Injectable Anticoagulants Revenue Market Share by Type
Figure 2016 North America Injectable Anticoagulants Revenue Market Share by Type
Table North America Injectable Anticoagulants Price by Type (2012-2017)
Table North America Injectable Anticoagulants Sales by Application (2012-2017)
Table North America Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure North America Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Table North America Market Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Injectable Anticoagulants Market Share (2012-2017)
Table Genentech (Roche) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech (Roche) Injectable Anticoagulants Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Injectable Anticoagulants Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Injectable Anticoagulants Market Share (2012-2017)
Table The Medicines Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table The Medicines Company Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure The Medicines Company Injectable Anticoagulants Market Share (2012-2017)
Table Aspen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aspen Injectable Anticoagulants Market Share (2012-2017)
Table Otsuka Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Otsuka Injectable Anticoagulants Market Share (2012-2017)
Figure United States Injectable Anticoagulants Sales and Growth Rate (2012-2017)
Figure United States Injectable Anticoagulants Revenue and Growth Rate (2012-2017)
Table United States Injectable Anticoagulants Sales by Type (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table United States Injectable Anticoagulants Revenue by Type (2012-2017)
Table United States Injectable Anticoagulants Revenue Market Share by Type (2012-2017)
Figure United States Injectable Anticoagulants Revenue Market Share by Type (2012-2017)
Table United States Injectable Anticoagulants Price by Type (2012-2017)
Table United States Injectable Anticoagulants Sales by Application (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure Canada Injectable Anticoagulants Sales and Growth Rate (2012-2017)
Figure Canada Injectable Anticoagulants Revenue and Growth Rate (2012-2017)
Table Canada Injectable Anticoagulants Sales by Type (2012-2017)
Table Canada Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Figure Canada Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table Canada Injectable Anticoagulants Revenue by Type (2012-2017)
Table Canada Injectable Anticoagulants Revenue Market Share by Type (2012-2017)
Figure Canada Injectable Anticoagulants Revenue Market Share by Type (2012-2017)
Table Canada Injectable Anticoagulants Price by Type (2012-2017)
Table Canada Injectable Anticoagulants Sales by Application (2012-2017)
Table Canada Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure Canada Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure Mexico Injectable Anticoagulants Sales and Growth Rate (2012-2017)
Figure Mexico Injectable Anticoagulants Revenue and Growth Rate (2012-2017)
Table Mexico Injectable Anticoagulants Sales by Type (2012-2017)
Table Mexico Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Figure Mexico Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Table Mexico Injectable Anticoagulants Revenue by Type (2012-2017)
Table Mexico Injectable Anticoagulants Revenue Market Share by Type (2012-2017)
Figure Mexico Injectable Anticoagulants Revenue Market Share by Type (2012-2017)
Figure 2016 Mexico Injectable Anticoagulants Revenue Market Share by Type
Table Mexico Injectable Anticoagulants Price by Type (2012-2017)
Table Mexico Injectable Anticoagulants Sales by Application (2012-2017)
Table Mexico Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure Mexico Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure North America Injectable Anticoagulants Sales and Growth Rate Forecast (2017-2022)
Figure North America Injectable Anticoagulants Revenue and Growth Rate Forecast (2017-2022)
Table North America Injectable Anticoagulants Sales Forecast by Countries (2017-2022)
Table North America Injectable Anticoagulants Sales Market Share Forecast by Countries (2017-2022)
Table North America Injectable Anticoagulants Sales Forecast by Type (2017-2022)
Table North America Injectable Anticoagulants Sales Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Injectable Anticoagulants
Figure Manufacturing Process Analysis of Injectable Anticoagulants
Figure Injectable Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Injectable Anticoagulants Major Players in 2016
Table Major Buyers of Injectable Anticoagulants
Table Distributors/Traders List